US 10188704
Enhanced melanoma cancer prevention by novel melanotropins
granted A61KA61K38/00A61K38/10
Quick answer
US patent 10188704 (Enhanced melanoma cancer prevention by novel melanotropins) held by Arizona Board of Regents on Behalf of the University of Arizona expires Mon Jan 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Arizona Board of Regents on Behalf of the University of Arizona
- Grant date
- Tue Jan 29 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K38/00, A61K38/10, A61K38/34, A61K8/64